Andros Pharmaceuticals Co.,Ltd Share Price

Equities

6917

TW0006917008

Pharmaceuticals

End-of-day quote Taipei Exchange 23:00:00 23/05/2024 BST 5-day change 1st Jan Change
21.3 TWD +0.95% Intraday chart for Andros Pharmaceuticals Co.,Ltd -1.62% -14.46%
Dynamic Chart
1 day+0.95%
1 week-1.62%
Current month-1.16%
1 month-0.23%
3 months-11.62%
6 months-19.47%
Current year-14.46%
More quotes
1 week
20.40
Extreme 20.4
21.70
1 month
20.40
Extreme 20.4
22.05
Current year
19.80
Extreme 19.8
26.60
1 year
19.80
Extreme 19.8
39.60
3 years
19.80
Extreme 19.8
46.30
5 years
19.80
Extreme 19.8
46.30
10 years
19.80
Extreme 19.8
46.30
More quotes
Managers TitleAgeSince
Chief Executive Officer - 30/06/08
Chief Operating Officer - -
More insiders
Andros Pharmaceuticals Co Ltd is a Taiwan-based company mainly engaged in the research, design, development, manufacture and sales of novel drug delivery systems and liposome formulation-related products. The products are focused on topical drugs and are developed with a focus on pain-related indications. The Company is mainly engaged in the authorization of product technology transfer, as well as the manufacture and sales of niche generic drugs and high-end skin care products. Niche generic drugs and high-end skin care products include LALP Cream, which is used for anesthesia before minor skin surgery and laser treatment; iMinos Solution, which is used for the treatment of androgenetic alopecia; and deoxyribonucleic acid (DNA) repair enzyme liposome (LipoT4N5), which has anti-wrinkle, anti-sun and anti-aging effects. The products are mainly sold in Hong Kong and Taiwan.
More about the company